These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2888205)

  • 1. Approaches to defining the relationship of maternal and developmental toxicity.
    Schardein JL
    Teratog Carcinog Mutagen; 1987; 7(3):255-71. PubMed ID: 2888205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental toxicity of 1,6-hexamethylene diisocyanate (HDI) in the Sprague-Dawley rat.
    Astroff AB; Sturdivant DW; Lake SG; Shiotsuka RN; Simon GS; Andrews LS
    Teratology; 2000 Oct; 62(4):205-13. PubMed ID: 10992262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal toxicity in humans and animals: effects on fetal development and criteria for detection.
    Khera KS
    Teratog Carcinog Mutagen; 1987; 7(3):287-95. PubMed ID: 2888207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of adult toxicity in developmental versus prechronic toxicology studies.
    Schwetz BA; Moorman MP
    Teratog Carcinog Mutagen; 1987; 7(3):211-23. PubMed ID: 2888202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus workshop on the evaluation of maternal and developmental toxicity work group I report: end points of maternal and developmental toxicity.
    Skalko RG; Johnson EM
    Teratog Carcinog Mutagen; 1987; 7(3):307-10. PubMed ID: 2888209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of environmental agents for developmental toxicity: current and emerging approaches.
    Dellarco VL; Kimmel CA
    Mutat Res; 1997 Dec; 396(1-2):205-18. PubMed ID: 9434870
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
    Burdan F; Szumilo J; Klepacz R
    Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental toxicity evaluation of sodium thioglycolate administered topically to Sprague-Dawley (CD) rats and New Zealand White rabbits.
    Tyl RW; Price CJ; Marr MC; Myers CB; van Birgelen AP; Jahnke GD
    Birth Defects Res B Dev Reprod Toxicol; 2003 Apr; 68(2):144-61. PubMed ID: 12866706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of maternal and fetal toxic dose responses in mammals.
    Rogers JM
    Teratog Carcinog Mutagen; 1987; 7(3):297-306. PubMed ID: 2888208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental toxicity of carbon black oil in mice.
    Hansen JM; Reynolds PR; Booth GM; Schaalje GB; Seegmiller RE
    Teratology; 2000 Oct; 62(4):227-32. PubMed ID: 10992264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the developmental toxicity of isoeugenol in Sprague-Dawley (CD) rats.
    George JD; Price CJ; Marr MC; Myers CB; Jahnke GD
    Toxicol Sci; 2001 Mar; 60(1):112-20. PubMed ID: 11222878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative developmental toxicities of aliphatic nitriles: in vivo and in vitro observations.
    Saillenfait AM; Sabaté JP
    Toxicol Appl Pharmacol; 2000 Mar; 163(2):149-63. PubMed ID: 10698673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between maternal toxicity and embryo/fetal effects.
    Chahoud I; Ligensa A; Dietzel L; Faqi AS
    Reprod Toxicol; 1999; 13(5):375-81. PubMed ID: 10560586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental effects of methyl benzimidazolecarbamate following exposure during early pregnancy.
    Cummings AM; Ebron-McCoy MT; Rogers JM; Barbee BD; Harris ST
    Fundam Appl Toxicol; 1992 Feb; 18(2):288-93. PubMed ID: 1601229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessments.
    Chernoff N; Rogers JM; Kavlock RJ
    Toxicology; 1989 Dec; 59(2):111-25. PubMed ID: 2686096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal factors in developmental toxicity.
    DeSesso JM
    Teratog Carcinog Mutagen; 1987; 7(3):225-40. PubMed ID: 2888203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acute maternal toxicity on fetal development in the mouse.
    Kavlock RJ; Chernoff N; Rogers EH
    Teratog Carcinog Mutagen; 1985; 5(1):3-13. PubMed ID: 2859660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Di(2-ethylhexyl) phthalate(DEHP) on mouse embryos development in vitro].
    Gao L; Li Y; Pei X; Chen X
    Wei Sheng Yan Jiu; 2003 May; 32(3):198-200. PubMed ID: 12914278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.